Shares of Celgene sank more than 8 percent after hours Wednesday following news that investment firm Wellington Management does not support Bristol-Myers acquisition of the biotechnology company.
div > div.group > p:first-child"> In January, Bristol-Myers Squibb announced its plans to buy cancer drugmaker Celgene in a cash and stock deal valued at $74 billion.
Wellington Management is the largest institutional holder of Bristol's common stock at about 8 percent. Wellington said in a release that it"does not believe that the Celgene transaction is an attractive path towards" business that"secures differentiated science and broadens the future revenue base."
Wellington said the acquisition asks Bristol's shareholders to accept too much risk while there are other paths to create value for shareholders. The investment company also worries the execution of the acquisition will be more difficult than depicted by company management.Celgene has also been working on an experiential gene therapy that is a highly competitive and potentiality profitable area of the biotech industry.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Macy’s Looks to Thin Upper Management as Sales FallMacy’s gave a mostly flat outlook for fiscal 2019 as the retailer said it would further streamline its management structure to reduce costs and be faster in responding to changing customer expectations.
Read more »
Oprah Winfrey's stake in Weight Watchers falls by $48 million after shares crater 30 percentAs of Tuesday's close, Winfrey's stake in Weight Watchers was valued at $160.18 million. It dropped by $45.7 million in a matter of minutes after the company reported disappointing earnings.
Read more »
Fitbit sees current-quarter revenue below estimates, shares fall 15 percentWearable device maker Fitbit Inc forecast first-quarter revenue below analysts&...
Read more »
Warren Buffett says he was close to making a 'very large' acquisition in the fourth quarterBuffett says he was close to making a 'very large' acquisition in the 4th quarter but it fell apart
Read more »
Warren Buffett says prospects poor for 'elephant-sized acquisition'Warren Buffett is hunting for 'an elephant-sized acquisition,' but he ...
Read more »